Abbott Expands its Directional Deep Brain Stimulation Therapy by Offering New MR-Conditional Labeling

- FDA approval of new software upgrade for Abbott's deep brain stimulation therapy enables advanced, patient-centric features for people living with Parkinson's disease and essential tremor
Source: Abbott.com - Category: Pharmaceuticals Source Type: news